相关实验视频
Updated: Apr 8, 2026

08:31
Porous Silicon Microparticles for Delivery of siRNA Therapeutics
Published on: January 15, 2015
10.9K
长效注射:从氧化多孔宿主中持续,线性释放孕激素避孕药
Geoffrey Hollett1, Ruhan Fan1, Tushar Kumeria2
1Materials Science & Engineering Program, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA, 92093, USA.
Advanced healthcare materials
|February 14, 2025
概括
多孔的二氧化微粒为疏水性孕激素提供了一种新的输送系统,使药物持续释放长达三个月. 这种方法克服了药物降解的挑战,并提高了长效避孕药的稳定性.
科学领域:
- 生物材料科学 生物材料科学
- 药物输送系统 药物输送系统
- 纳米技术纳米技术
背景情况:
- 可注射的疏水性孕激素避孕药需要稳定的血度.
- 目前的输送方法面临着药物稳定性和释放特征的挑战.
研究的目的:
- 调查多孔二氧化 (pSiO2) 微粒作为孕药的药物输送载体.
- 优化长效避孕药的药物加载和持续释放特征.
主要方法:
- 通过电化学化和热氧化制造pSiO2微粒.
- 孕激素 (乙凝,凝,乙乙) 的融透到pSiO2中等孔中.
- 药物加载,晶度 (X射线衍射) 和体外药物释放的特征.
- 在老鼠体内进行试点体内研究,以评估生物相容性和毒性.
主要成果:
- 通过与胆固醇的融化透,实现了高质量负荷 (>50%) 的赛格乙酸 (SEG) 和甲 (LNG).
- 在体外持续释放药物长达3个月,并减少突发释放和改善稳定状态度.
- 在25周的老鼠体内研究中,装有SEG的pSiO2微粒没有显示出毒性迹象.
结论:
- 融入pSiO2微粒的透是加载疏水性孕激素的可行方法,克服了降解问题.
- 这种输送系统提供持续释放,可能改善避孕药的有效性和患者的遵守性.
- 多孔的二氧化微粒是生物相容的,适合长期的孕激素输送.
相关概念视频
Modified-Release Drug Delivery Systems: Rate-Programmed II
91
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
91
Modified-Release Drug Delivery Systems: Rate-Programmed I
106
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
106
Intrauterine Drug Delivery Systems
130
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
130

